TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer

Oncogene

Volumn 16, Issue 13, 1998, Pages 1671-1679

  Erber, Ralf ^a   Conradt, Christian ^a   Homann, Nils ^a   Enders, Christel ^a   Finckh, Martin ^b   Dietz, Andreas ^a   Weidauer, Hagen ^a   Bosch, Franz X ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b HELIOS KLINIKUM BERLIN BUCH   (Germany)

Author keywords

Clinical course; Head and neck cancer; Mutation types; Tp53

Indexed keywords

MICROSATELLITE DNA; PROTEIN P53; ZINC FINGER PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; FEMALE; GENE LOSS; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0032473823     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201690     Document Type: Article

References (27)

1. Aas T, Borresen AL, Geisler S, Smith Sorensen B, Johnsen H, Varhaug JE, Akslen LA and Lonning PE. (1996). Nat. Med., 2, 811-814.
2. Ahomadegbe JC, Barrois M, Fogel S, Le Bihan ML, Douc Rasy S, Duvillard P, Armand JP and Riou G. (1995). Oncogene, 10, 1217-1227.
3. Andersen TI, Holm R, Nesland JM, Heimdal KR, Ottestad L and Borresen AL. (1993). Br. J. Cancer, 68, 540-548.
4. Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A, Dumphy E, Mick R, Yandell D, Weichselbaum RR. (1992). Cancer Res., 52, 4832-4836.
5. Bergh J, Norberg T, Sjogren S, Lindgren A, and Holmberg L. (1995). Nat. Med., 1, 1029-1034.
6. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, Correo R, Eby YJ, Ruppert JM and Sidransky D. (1993). Cancer Res., 53, 4477-4480.
7. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
8. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nat. Genet., 4, 42-46.
9. Forrester K, Lupold SE, Ott VL, Chay CH, Band V, Wang XW and Harris CC. (1995). Oncogene, 10, 2103-2111.
10. Friedlander P. Haupt Y, Prives C and Oren M. (1996). Mol. Cell Biol., 9, 4961-4971.
11. Goh HS, Yao J and Smith DR. (1995). Cancer Res., 55, 5217-5221.
12. Greenblatt MS, Bennett WP, Hollstein M and Harris CC, (1994). Cancer Res., 54, 4855-4878.
13. Hamelin R, Laurent-Puig P, Olschwang O, Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ and Thomas G. (1994). Gastroenterology, 106, 42-48.
14. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC. (1996). Nucleic Acids Res., 24, 141-146.
15. Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J and Haas M. (1994). Am. J. Pathol., 145, 702-714.
16. Jones MH and Nakamura Y. (1992). Genes Chromosomes Cancer, 5, 89-90.
17. Kieser A, Weich HA, Brandner G, Marme D and Kolch W. (1994). Oncogene, 9, 963-969.
18. Ko LJ and Prives C. (1996). Genes Dev., 10, 1054-1072.
19. Levine AJ. (1997). Cell, 88, 323-331.
20. Lin J, Teresky AK and Levine AJ. (1995). Oncogene, 10, 2387-2390.
21. Michalovitz D, Halevy O and Oren M. (1991). J. Cell. Biochem., 45, 22-29
22. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffmann B and Reed JC. (1994). Oncogene, 9, 1799-1805.
23. Nees M, Homann N, Discher H, Andl T, Enders C, Herold Mende C, Schuhmann A and Bosch FX. (1993). Cancer Res., 53, 4189-4196.
24. Ory K, Legros Y, Auguin C and Soussi T. (1994). EMBO J., 13, 3496-3504.
25. Rolley N, Butcher S and Milner J. (1995). Oncogene, 11, 763-770.
26. Soder AI, Hopman AH, Ramaekers FC, Conradt C and Bosch FX. (1995). Cancer Res., 55, 5030-5037.
27. Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KJ, Evans DG and Birch JM. (1997). Oncogene, 14, 865-871.